Danaflex-Lab ApS: Financial statements 2024
CVR: 43725157
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Danaflex-Lab ApS (CVR 43725157) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 322,661 and a net result of DKK 247,320 compared with DKK -87,321 the year before. Equity in the 2024 report amounted to DKK 199,999. The solvency ratio was 20.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 322,661
- Profit/Loss
- DKK 247,320
- Equity
- DKK 199,999
- Total Assets
- DKK 977,507
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Danaflex-Lab ApS has published its annual report for 2023. Gross profit came to DKK -103,500, and the net result was DKK -87,321.
About Danaflex-Lab ApS
Danaflex-Lab ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2022. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Kristian Skov Alanin. The company is owned by ALANIN HOLDING ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 492,957 and a net result of DKK 206,339 compared with DKK 247,320 the year before. Equity in the 2025 report amounted to DKK 406,337.